HDFC Pharma and Healthcare Fund - Direct - Growth

Equity Scheme by HDFC Asset Management Company Limited

3Y Returns (CAGR)
28.77%
Expense Ratio
0.93%

as of 01/03/2026

AUM
₹765.67 Cr

Qtr End: Jun 26

NAV
₹21.23

as of 16/10/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M-2.25%-8.69%13.13%
6M15.61%33.65%12.78%
1Y19.12%19.12%13.65%
3Y113.54%28.77%14.28%
5YN/AN/AN/A
Scheme Details
Launch Date
14/09/2023
Fund Age
3.1 years
Minimum Investment
₹100
Fund House
HDFC Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions